AbTherx
Gavin Thurston currently serves on the Scientific Advisory Board at AbTherx, beginning this role in July 2023. Prior to this, Gavin Thurston spent 22 years at Regeneron Pharmaceuticals, Inc., from January 2001 to December 2022, where the position held was Senior Vice President of Oncology Research. During this tenure, Gavin Thurston successfully developed and led the oncology research group, contributing to numerous projects and collaborating with a diverse team of professionals.
This person is not in any teams
AbTherx
AbTherx is advancing medicine with revolutionary technologies that accelerate and enable therapeutic antibody discovery. Through an exclusive partnership with Gilead Sciences, AbTherx has released Atlas™ Mice, a suite of novel transgenic technologies designed for unmatched performance and FTO. For over 20 years, AbTherx’s passionate, innovative, and collaborative team has pushed the boundaries of antibody discovery technologies, leading to over 1,000 successful antibody discovery campaigns and 13 marketed therapeutics. AbTherx’s industry-leading team creates transformative solutions to overcome the most demanding challenges in delivering innovative medicines. Committed to making its technologies accessible to all, AbTherx offers flexible partnering models that meet the needs of drug developers of all sizes.